feed,title,long_url,short_url
MarketWatch,Theravance Biopharma initiated at overweight with $29 price target at JPMorgan,http://feeds.marketwatch.com/~r/marketwatch/realtimeheadlines/~3/eDGrnE4Gor0/quotes.asp,https://j.mp/3f9e2ur
